T
Thomas Brunner
Researcher at University of Konstanz
Publications - 511
Citations - 26076
Thomas Brunner is an academic researcher from University of Konstanz. The author has contributed to research in topics: Apoptosis & Medicine. The author has an hindex of 75, co-authored 448 publications receiving 23438 citations. Previous affiliations of Thomas Brunner include University Medical Center Freiburg & University of Oxford.
Papers
More filters
Journal ArticleDOI
Quantification of the release of inorganic elements from biofuels
Flemming Frandsen,Simone Cornelia van Lith,Rob Korbee,Patrik Yrjas,Rainer Backman,Ingwald Obernberger,Thomas Brunner,Markus Jöller +7 more
TL;DR: In this paper, the authors compared the results from the lab-scale fixed-bed release data with the results obtained from the fuel characterization techniques and from the equilibrium calculations and found that a good correlation was found between the lab scale and pilot scale fixed bed release data.
Journal ArticleDOI
IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils
TL;DR: The induction of Pim1 leading to PI3-kinase-independent survival as described here for basophils may also be a relevant antiapoptotic mechanism in other terminally differentiated leukocyte types.
Journal ArticleDOI
Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RASG12V oncogene
Franz S. Schreiber,Therese B. Deramaudt,Thomas Brunner,Michael I. Boretti,Keith J. Gooch,Doris A. Stoffers,Eric J. Bernhard,Anil K. Rustgi +7 more
TL;DR: Induction of cell-cycle regulators and lack of mitogen-activated protein kinase hyperstimulation likely are responsible for constraining activated Ki-RAS(G12V)-mediated proliferation.
Journal ArticleDOI
IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival
Serena Lunardi,Nigel B. Jamieson,Su Yin Lim,Kristin L. Griffiths,Manuela Carvalho-Gaspar,Osama Al-Assar,Sabira Yameen,Ross Carter,Colin J. McKay,Gabriele Spoletini,Stefano D'Ugo,Michael A. Silva,Owen J. Sansom,Klaus-Peter Janssen,Ruth J. Muschel,Thomas Brunner +15 more
TL;DR: It is suggested that, in pancreatic cancer, CXCR3+ Tregs can be recruited by IP-10 expressed by PSCs in the tumor stroma, leading to immunosuppressive and tumor-promoting effects.
Journal ArticleDOI
Thiazolides inhibit growth and induce glutathione-S-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells
Joachim Müller,Daniel Sidler,Ueli Nachbur,Jonathan M. Wastling,Thomas Brunner,Andrew Hemphill +5 more
TL;DR: Interestingly, the apoptosis‐inducing effect of thiazolides appeared to be cell cycle‐dependent and induction of cell cycle arrest substantially inhibited the cell death‐inducing activity of these compounds.